Sandra Turcotte

4.4k total citations
29 papers, 1.5k citations indexed

About

Sandra Turcotte is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Sandra Turcotte has authored 29 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Cancer Research and 10 papers in Epidemiology. Recurrent topics in Sandra Turcotte's work include Cancer, Hypoxia, and Metabolism (10 papers), Autophagy in Disease and Therapy (10 papers) and Epigenetics and DNA Methylation (8 papers). Sandra Turcotte is often cited by papers focused on Cancer, Hypoxia, and Metabolism (10 papers), Autophagy in Disease and Therapy (10 papers) and Epigenetics and DNA Methylation (8 papers). Sandra Turcotte collaborates with scholars based in Canada, United States and New Zealand. Sandra Turcotte's co-authors include Amato J. Giaccia, Richard Béliveau, Richard R. Desrosiers, Denise A. Chan, Patrick D. Sutphin, William A. Denny, Michael P. Hay, Phuong Nguyen, Jack U. Flanagan and Muriel Bonnet and has published in prestigious journals such as Cancer Cell, Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Sandra Turcotte

25 papers receiving 1.5k citations

Peers

Countries citing papers authored by Sandra Turcotte

Since Specialization

Citations

This map shows the geographic impact of Sandra Turcotte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Turcotte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Turcotte more than expected).

Fields of papers citing papers by Sandra Turcotte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Turcotte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Turcotte. The network helps show where Sandra Turcotte may publish in the future.

Co-authorship network of co-authors of Sandra Turcotte

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Turcotte. A scholar is included among the top collaborators of Sandra Turcotte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Turcotte. Sandra Turcotte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MicroRNA profiling identifies VHL/HIF-2α dependent miR-2355-5p as a key modulator of clear cell Renal cell carcinoma tumor growth 2025 ·Cancer Cell International ·(unknown), (unknown), Patrick O. Richard, Michel Pavic, Tamiko Nishimura, Yasser Riazalhosseini, Nicolas Crapoulet, (unknown), Sandra Turcotte	0
2	The role of 12-lipoxygenase in regulating megakaryocyte maturation and platelet-like particles production 2025 ·Thrombosis Research ·(unknown), (unknown), (unknown), Kate L. Graham, (unknown), (unknown), (unknown), (unknown), Éric P. Allain, David A. Barnett, Sandra Turcotte, Luc H. Boudreau	0
3	Loss of SETD2 in wild‐type VHL clear cell renal cell carcinoma sensitizes cells to STF ‐62247 and leads to DNA damage, cell cycle arrest, and cell death characteristic of pyroptosis 2024 ·Molecular Oncology ·(unknown), Sandra Turcotte	0
4	Abstract 3956: Identifying PIKfyve as potential target in clear cell renal cell carcinoma with a loss of the von Hippel-Lindau tumor suppressor gene 2023 ·Cancer Research ·(unknown), Sandra Turcotte	0
5	A Compendium of Information on the Lysosome 2021 ·Frontiers in Cell and Developmental Biology ·(unknown), (unknown), Sandra Turcotte	33
6	STF-62247 accumulates in lysosomes and blocks late stages of autophagy to selectively target von Hippel-Lindau-inactivated cells 2019 ·American Journal of Physiology-Cell Physiology ·(unknown), (unknown), (unknown), Sandra Turcotte	16
7	Discovery of a novel 2,5-dihydroxycinnamic acid-based 5-lipoxygenase inhibitor that induces apoptosis and may impair autophagic flux in RCC4 renal cancer cells 2019 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sandra Turcotte, Marc E. Surette, Mohamed Touaibia	16
8	¹H NMR metabolomics analysis of renal cell carcinoma cells: Effect of VHL inactivation on metabolism 2015 ·International Journal of Cancer ·Miroslava Čuperlović‐Culf, (unknown), Mohamed Touaibia, (unknown), (unknown), (unknown), Sandra Turcotte	26
9	Autophagy and Cell Death to Target Cancer Cells: Exploiting Synthetic Lethality as Cancer Therapies 2013 ·Advances in experimental medicine and biology ·(unknown), (unknown), Sandra Turcotte	34
10	Targeting GLUT1 and the Warburg Effect in Renal Cell Carcinoma by Chemical Synthetic Lethality 2011 ·Science Translational Medicine ·Denise A. Chan, Patrick D. Sutphin, Phuong Nguyen, Sandra Turcotte, Edwin W. Lai, Alice Banh, Gloria E. Reynolds, Jen‐Tsan Chi, Jason Wu, David E. Solow-Cordero, Muriel Bonnet, Jack U. Flanagan, Donna M. Bouley, Edward E. Graves, William A. Denny, Michael P. Hay, Amato J. Giaccia	456
11	Targeting cancer cells through autophagy for anticancer therapy 2010 ·Current Opinion in Cell Biology ·Sandra Turcotte, Amato J. Giaccia	104
12	Targeted therapy for the loss of von Hippel-Lindau in renal cell carcinoma: A novel molecule that induces autophagic cell death 2008 ·Autophagy ·Sandra Turcotte, Patrick D. Sutphin, Amato J. Giaccia	14
13	A Molecule Targeting VHL-Deficient Renal Cell Carcinoma that Induces Autophagy 2008 ·Cancer Cell ·Sandra Turcotte, Denise A. Chan, Patrick D. Sutphin, Michael P. Hay, William A. Denny, Amato J. Giaccia	208
14	A novel molecule targeting VHL-deficient renal cell carcinoma that induces autophagic cell death 2007 ·Molecular Cancer Therapeutics ·Sandra Turcotte, Patrick D. Sutphin, Denise A. Chan, Michael P. Hay, William A. Denny, Amato J. Giaccia	2
15	HIF Gene Expression in Cancer Therapy 2007 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Denise A. Chan, Adam J. Krieg, Sandra Turcotte, Amato J. Giaccia	22
16	Targeting the Loss of the von Hippel-Lindau Tumor Suppressor Gene in Renal Cell Carcinoma Cells 2007 ·Cancer Research ·Patrick D. Sutphin, Denise A. Chan, (unknown), Sandra Turcotte, Adam J. Krieg, Amato J. Giaccia	27
17	von Hippel‐Lindau tumor suppressor protein stimulation by thrombin involves RhoA activation 2004 ·International Journal of Cancer ·Sandra Turcotte, Richard R. Desrosiers, (unknown), Richard Béliveau	5
18	Hypoxia upregulates von Hippel-Lindau tumor-suppressor protein through RhoA-dependent activity in renal cell carcinoma 2004 ·American Journal of Physiology-Renal Physiology ·Sandra Turcotte, Richard R. Desrosiers, Richard Béliveau	34
19	Diallyl disulfide, a chemopreventive agent in garlic, induces multidrug resistance-associated protein 2 expression 2004 ·Biochemical and Biophysical Research Communications ·Michel Demeule, (unknown), Sandra Turcotte, Anthony Régina, Julie Jodoin, Richard Béliveau	34
20	Sensitization to the Cytotoxicity of Melphalan by Ethacrynic Acid and Hyperthermia in Drug-Sensitive and Multidrug-Resistant Chinese Hamster Ovary Cells 2001 ·Radiation Research ·Sandra Turcotte, Diana A. Averill‐Bates	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact